RPSAP13

Across TCGA pan-cancer cohorts, RPSAP13 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RPSAP13 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher RPSAP13 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPSAP13 expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCEC show a favorable association.

KICH, BRCA, and LGG are the cancer types where RPSAP13 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Quartile	II,III,IV	0.379	0.827	<.001	80	view →
BRCA	OS	Tertile	III,IV	0.808	0.496	.002	34	view →
LGG	OS	Quartile	All	0.384	0.528	<.001	34	view →
CHOL	OS	Tertile	III,IV	0.136	0.859	.003	27	view →
LIHC	DFS	Quartile	All	0.327	0.459	.001	21	view →
UCEC	DFS	Tertile	IV	0.766	0.253	.010	18	view →
ACC	OS	Tertile	II,III,IV	0.157	0.706	.002	18	view →
READ	OS	Tertile	All	0.827	0.543	.015	17	view →
ESCA	OS	Median	III,IV	0.668	0.337	.016	15	view →
UVM	OS	Quartile	III,IV	0.248	0.759	.019	12	view →
THCA	OS	Tertile	IV	0.857	1.000	.004	12	view →
MESO	OS	Tertile	All	0.436	0.587	.025	11	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RPSAP13–KICH (DFS)

Open the KICH breakdown →